IMSPEX DIAGNOSTICS LIMITED

Company number 07533570 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

IMSPEX Diagnostics Limited — Investment Risk Analysis

1. Risk Rating: HIGH

The company exhibits multiple material risk indicators, most notably an explicit going concern qualification in the directors' own accounting policies, severe working capital deterioration in the most recent financial year, and an equity erosion event in 2025. Mitigating factors exist — primarily the controlling stake held by Hanon Group Inc Limited — but on the standalone evidence, the risk profile is elevated.


2. Key Concerns

(a) Negative Working Capital and Going Concern Flag

Net current liabilities stand at £1,801,610 as at 31 December 2025 (current liabilities of £1,875,132 against current assets of only £73,522). The directors have explicitly acknowledged in Note 1.2 of the accounts that there are "certain material uncertainties which may cause doubt on the company's ability to continue as a going concern." This is a direct disclosure from management and warrants serious attention.

(b) Equity Erosion in 2025

Profit and loss reserves swung from £1,130,052 positive to a deficit of £62,896 during 2025, implying an annual loss of approximately £1.19 million. Net assets consequently fell from £2,537,806 to £1,344,858 — a 47% decline year-on-year. Without P&L disclosure (the directors have elected to omit the profit and loss account under small companies' exemption), the underlying drivers are not transparent from public filings alone.

(c) Liquidity Mismatch

Cash at bank is £58,346, which is wholly inadequate against £1.875m of liabilities falling due within one year. The very low turnover (£104,071 in 2021; revenue not separately reported for 2022–2025) appears wholly insufficient to service obligations from operations. The company is evidently reliant on continued shareholder/group support to remain solvent.


3. Positive Indicators

  • Parent group backing: Hanon Group Inc Limited owns 50–75% of shares and voting rights, and name shown to subscribers (a director) holds significant influence or control. Loans from fellow group companies are referenced in the accounting policies, suggesting intercompany funding mechanisms exist.
  • Substantial intangible asset base: £3,417,465 in capitalised patents and development costs represents potentially valuable IP in gas chromatography–ion mobility spectrometry (GC-IMS) analytical instrumentation.
  • Stable corporate status: Active registration, regular and compliant filings, no history of insolvency proceedings, no overdue returns, and 15 years of continuous trading.
  • Recent directorial stability: Two serving directors provide governance continuity following the resignation of name shown to subscribers in October 2026.

4. Due Diligence Notes

Specific items requiring further investigation:

  1. Group support arrangements: Obtain details of formal or informal letters of comfort, subordination agreements, or funding undertakings from Hanon Group Inc Limited. The standalone going concern is highly questionable without such backing.
  2. 2025 P&L drivers: As the profit and loss account has been omitted from public accounts, request management accounts to identify whether the £1.19m loss was driven by impairment of intangibles, restructuring, R&D write-down, or trading losses.
  3. Nature of current liabilities: Determine the composition of the £1.875m short-term creditor balance — particularly the extent of intra-group debt versus third-party obligations, and any tax-related exposures given the £283,951 provision.
  4. Intangible asset recoverability: With development costs and patents comprising ~98% of total assets, an impairment review is overdue if losses persist.
  5. Filing date anomaly: The accounts information suggests the next accounts are not due until 30 September 2027 — this is unusually late for a 31 December year-end and should be verified (it may reflect a filed extension or an error).
  6. PSC and governance: Clarify the relationship between name shown to subscribers (individual PSC) and Hanon Group Inc Limited (corporate PSC), and any cross-directorships within the group structure.
  7. Revenue trajectory: Request order book, pipeline, and revenue forecasts — the company appears to be either a dormant trading entity or a development-stage business within a wider group structure.

Names of the people mentioned are shown to subscribers. See subscription

Perspective: Investment Risk Assessor · Model: minimax-m3 · Generated 16 October 2026